13-14th of February, GPX Medical exhibited at neonatal intensive care conference 2ndLAUNCH in Paris, France.

GPX Medical’s CEO Hanna Sjöström discussed the need for continuous lung monitoring of preterm born infants with Prof. De Luca, President Elect European Society for Pediatrics and Neonatal Critical Care, Prof. Sriram at University of Chicago, Nadya Yousef and 350 other neonatologist from over 40 countries dedicated to improve the care of preterm born infants.

GPX Medical’s medical device for continuous lung monitoring, NEOLA, received great interest from the neonatal intensive care community and show that there is a clear need for the product.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsiduary to Gasporox AB (publ) with the aim to develop and commercialize medical applications of the GASMAS technology. The company is owned by Gasporox AB (publ) to 53,3%, by Norsk Elektro Optikk AS to 36,2% and by the team to 10,5%. The company is located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hs@gpxmedical.se

Contact

GPX Medical AB
Maskinvägen 1
227 30 Lund
Sweden
info@gpxmedical.se